Myomo (MYO) Non Operating Investment Income (2022 - 2023)
Myomo's (MYO) quarterly Non Operating Investment Income came in at -$70124.0 in Q3 2023, down 321.11% on a YoY basis from $31713.9 in Q3 2022, and down 460.36% quarter-over-quarter from -$12514.0 in Q2 2023.
Powered by 
Analysis
Myomo (MYO) Non Operating Investment Income (2022 - 2023) Analysis & Trends
Myomo (MYO) has reported Non Operating Investment Income for 2 consecutive years, with -$70124.0 the latest figure, recorded in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -70,124.00 |
| Jun 30, 2023 | -12,514.00 |
| Sep 30, 2022 | -16,652.00 |
| Jun 30, 2022 | -33,208.00 |